Your browser doesn't support javascript.
loading
Aberrant phase separation and nucleolar dysfunction in rare genetic diseases.
Mensah, Martin A; Niskanen, Henri; Magalhaes, Alexandre P; Basu, Shaon; Kircher, Martin; Sczakiel, Henrike L; Reiter, Alisa M V; Elsner, Jonas; Meinecke, Peter; Biskup, Saskia; Chung, Brian H Y; Dombrowsky, Gregor; Eckmann-Scholz, Christel; Hitz, Marc Phillip; Hoischen, Alexander; Holterhus, Paul-Martin; Hülsemann, Wiebke; Kahrizi, Kimia; Kalscheuer, Vera M; Kan, Anita; Krumbiegel, Mandy; Kurth, Ingo; Leubner, Jonas; Longardt, Ann Carolin; Moritz, Jörg D; Najmabadi, Hossein; Skipalova, Karolina; Snijders Blok, Lot; Tzschach, Andreas; Wiedersberg, Eberhard; Zenker, Martin; Garcia-Cabau, Carla; Buschow, René; Salvatella, Xavier; Kraushar, Matthew L; Mundlos, Stefan; Caliebe, Almuth; Spielmann, Malte; Horn, Denise; Hnisz, Denes.
Afiliación
  • Mensah MA; Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Niskanen H; BIH Biomedical Innovation Academy, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Magalhaes AP; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Basu S; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Kircher M; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Sczakiel HL; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Reiter AMV; Exploratory Diagnostic Sciences, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Elsner J; Institute of Human Genetics, University Hospitals Schleswig-Holstein, University of Lübeck and Kiel University, Lübeck, Kiel, Germany.
  • Meinecke P; Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Biskup S; BIH Biomedical Innovation Academy, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Chung BHY; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Dombrowsky G; Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Eckmann-Scholz C; Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Hitz MP; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hoischen A; Center for Genomics and Transcriptomics (CeGaT), Tübingen, Germany.
  • Holterhus PM; Department of Pediatrics and Adolescent Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Hülsemann W; Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kahrizi K; Department of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany.
  • Kalscheuer VM; Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kan A; Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Krumbiegel M; Department of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany.
  • Kurth I; Department of Internal Medicine, Radboud Institute for Molecular Life Sciences, Radboud Expertise Center for Immunodeficiency and Autoinflammation and Radboud Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Leubner J; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Longardt AC; Department of Pediatrics, Pediatric Endocrinology and Diabetes, University Hospital Schleswig-Holstein, Schleswig-Holstein, Germany.
  • Moritz JD; Handchirurgie, Katholisches Kinderkrankenhaus Wilhelmstift, Hamburg, Germany.
  • Najmabadi H; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Skipalova K; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Snijders Blok L; Department of Obstetrics and Gynaecology, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
  • Tzschach A; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Wiedersberg E; Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University Hospital, Aachen, Germany.
  • Zenker M; Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Garcia-Cabau C; Department of Pediatrics, University Hospital Center Schleswig-Holstein, Kiel, Germany.
  • Buschow R; Department of Radiology and Neuroradiology, Pediatric Radiology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Salvatella X; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Kraushar ML; Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Mundlos S; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Caliebe A; Institute of Human Genetics, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Spielmann M; Zentrum für Kinder-und Jugendmedizin, Helios Kliniken Schwerin, Schwerin, Germany.
  • Horn D; Institute of Human Genetics, University Hospital, Otto-von-Guericke University, Magdeburg, Germany.
  • Hnisz D; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Nature ; 614(7948): 564-571, 2023 02.
Article en En | MEDLINE | ID: mdl-36755093
ABSTRACT
Thousands of genetic variants in protein-coding genes have been linked to disease. However, the functional impact of most variants is unknown as they occur within intrinsically disordered protein regions that have poorly defined functions1-3. Intrinsically disordered regions can mediate phase separation and the formation of biomolecular condensates, such as the nucleolus4,5. This suggests that mutations in disordered proteins may alter condensate properties and function6-8. Here we show that a subset of disease-associated variants in disordered regions alter phase separation, cause mispartitioning into the nucleolus and disrupt nucleolar function. We discover de novo frameshift variants in HMGB1 that cause brachyphalangy, polydactyly and tibial aplasia syndrome, a rare complex malformation syndrome. The frameshifts replace the intrinsically disordered acidic tail of HMGB1 with an arginine-rich basic tail. The mutant tail alters HMGB1 phase separation, enhances its partitioning into the nucleolus and causes nucleolar dysfunction. We built a catalogue of more than 200,000 variants in disordered carboxy-terminal tails and identified more than 600 frameshifts that create arginine-rich basic tails in transcription factors and other proteins. For 12 out of the 13 disease-associated variants tested, the mutation enhanced partitioning into the nucleolus, and several variants altered rRNA biogenesis. These data identify the cause of a rare complex syndrome and suggest that a large number of genetic variants may dysregulate nucleoli and other biomolecular condensates in humans.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nucléolo Celular / Proteína HMGB1 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nucléolo Celular / Proteína HMGB1 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article País de afiliación: Alemania